Close

BIO Letter on Cloning to President Bush

The Honorable George W. BushPresident of the United StatesThe White House1600 Pennsylvania Avenue, NWWashington, DC 20500

Dear Mr. President:

Recently certain groups have...

BIO Says Bush Proposal On Medicare Drug Plan Moves Debate In Positive Direction

WASHINGTON, DC (January 30, 2001) –Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on President George W. Bush’s Immediate Helping Hand...

BIO’s CEO & Investor Conference Features Companies Leading Industry’s Financial Surge On Wall Street

WASHINGTON, D.C. (January 25, 2001) – The BiotechnologyIndustry Organization’s (BIO) CEO & Investor Conference next month in New York will showcase the companies whose technological and biomedical...

BIO Position on Stem Cell Research

As expressed in a joint letter to President-Elect Bush.

BIO Supportive of FDA Announcement on Biotech Foods

(Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today regarding a notice of an FDA proposed rule published in today’s Federal Register....

BIO Raises Concerns About FDA’s Proposed Rule On Disclosure Of Gene Therapy Trial Data

WASHINGTON, D.C. (January 17, 2001) -- Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) issued the following statement on the U.S. Food and Drug Administration’s (FDA)...

BIO names Sharon L. Cohen, senior health policy strategist, as new Vice-President

BIO seeks strong role in Medicare debate

WASHINGTON, D.C. (January 9, 2001) – The Biotechnology Industry Organization (BIO) today named Sharon L. Cohen BIO’s first vice president for...

BIO Issues Statement On PTO’s Final Gene-Based Patent Guidelines

WASHINGTON, D.C. (January 5, 2001) - Lila Feisee, director of intellectual property for the Biotechnology Industry Organization (BIO), issued the following statement on the U.S. Patent and...

CEO & Investor Conference Expected to Attract 1,500 Biotech Leaders and Investors

WASHINGTON, D.C. (December 22, 2000) - The Biotechnology Industry Organization (BIO) will host the third annual CEO & Investor Conference, "Investing in Biotechnology: The Value, The Risks,...

BIO names new VP of Government Relations

Lee Rawls, Chief of Staff to US Senator Bill Frist, Named BIO's new Vice President for Government Relations

WASHINGTON, D.C. (December 18, 2000) – “I am delighted to make this...